5-Azocytidine-induced 6-thioguanine resistance at the gpt locus in AS52 cells: Cellular response

Environmental and Molecular Mutagenesis

Volumn 28, Issue 2, 1996, Pages 100-106

  Spencer, Diane L ^a   Caspary, William J ^a   Hines, Kimberly C ^a   Tindall, Kenneth R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

5 Azacytidine; 6 Thioguanine resistance; AS52 cells; Expression; gpt gene; Mutagenesis

Indexed keywords

AZACITIDINE; TIOGUANINE; ANTINEOPLASTIC ANTIMETABOLITE; BACTERIAL PROTEIN; ESCHERICHIA COLI PROTEIN; GLYCOSYLTRANSFERASE; GPT PROTEIN, E COLI; MUTAGENIC AGENT; PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CHINESE HAMSTER; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG RESISTANCE; GENE INDUCTION; MUTAGENESIS; NONHUMAN; OVARY CELL; ANIMAL; CELL DIVISION; CHO CELL; DRUG EFFECT; GENETICS; HAMSTER; MUTATION; TIME;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BACTERIAL PROTEINS; CELL DIVISION; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ESCHERICHIA COLI PROTEINS; MUTAGENESIS; MUTAGENS; MUTATION; PENTOSYLTRANSFERASES; PROTEINS; THIOGUANINE; TIME FACTORS;

EID: 0029662074     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1996)28:2<100::AID-EM5>3.0.CO;2-J     Document Type: Article

References (33)

1. Amacher D, Turner G (1987): The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cell. Mutat Res 176:123-131.
2. Banerjee A, Benedict W (1979): Production of sister chromatid exchanges by various cancer chemotherapeutic agents. Cancer Res 39:797-799.
3. 1)Cl-3 cells by cancer chemotherapeutic agents. Cancer Res 37:2202-2208.
4. Bouck N, Kokkinakis D, Ostrowsky J (1984): Induction of a step in carcinogenesis that is normally associated with mutagenesis by non-mutagenic concentrations of 5-azacylidine. Mol Cell Biol 4:1231-1237.
5. Call K, Jensen J, Liber H, Thilly W (1986): Studies of mutagenicity and clastogenicity of 5-azacytidine in human lymphoblasts and Salmonella typhimurium. Mutat Res 160:249-257.
6. Can BI, Reilly JG, Smith SS, Winberg C, Riggs A (1984): The tumorigenicity of 5-azacytidine in the male Fischer rat. Carcinogenesis 5:1583-1590.
7. Constantinides PG, Jones PA, Gevers W (1977): Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature 267:364-366.
8. Friedman S (1979): The effect of 5-azacytidine on E. coli DNA methylase. Biochem Biophys Res Commun 89:1328-1333.
9. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z (1993): The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53:3186-3192.
10. Jones PA, Taylor SM (1980): Cellular differentiation, cytidine analogs and DNA methylation. Cell 20:85-93.
11. Jones P, Taylor S, Mohandas T, Shapiro L (1982): Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxy-cytidine. Proc Natl Acad Sci USA 79:1215-1219.
12. 1: Evidence for an inducible repair response. Cancer Res 47:1993-2001.
13. Karon M, Benedict WF (1972): Chromatid breakage: Differential effect of inhibitors and synthesis during G2 phase. Science 178:62.
14. Kizaki H, Ohnishi Y, Azuma Y, Mizuno Y, Ohsaka F (1992): 1-β-D-Arabinosylcytosine and 5-azacytidine induce internucleosomal DNA fragmentation and cell death in thymocytes. Immunopharmacology 24:219-227.
15. Lal D, Som S, Friedman S (1988): Survival and mutagenic effects of 5-azacytidine in Escherichia coli. Mutat Res 193:229-236.
16. Landolph JR, Jones PA (1982): Mutagenicity of 5-azacytidine and related nucleosides in C3H10T1/2 clone 8 and V79 cells. Cancer Res 42:817-823.
17. Lavia P, Ferraro M, Micheli A, Olivieri G (1985): Effect of 5-azacytidine (5-aza C) on the induction of chromatid aberrations (CA) and sister-chromatid exchanges (SCE). Mutat Res 149:463-467.
18. Li LH, Olin EJ, Fraser TJ, Bhuyan BK (1970): Phase specificity of 5-azacytidine against mammalian cells in tissue culture. Cancer Res 30:2770-2775.
19. McGregor DB, Brown AG, Cattanach P, Shepherd W, Riach C, Daston DS, Caspary WJ (1989): TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine. Carcinogenesis 10:2003-2008.
20. NCI (1978): "Bioassay of 5-Azacytidine for Possible Carcinogenicity." Bethesda, MD: National Cancer Institute.
21. Nelson JM, Braby LA, Melting NF, Roesch, WC (1990): Multiple components of split-dose repair in plateau-phase mammalian cells: A new challenge for phenomenological modelers. Radiat Res 121:154-160.
22. Podger DM (1983): Mulagenicity of 5-azacytidine in Salmonella typhimurium. Mutat Res 121:1-6.
23. Spencer DL, Mines KC, Caspary WJ (1994): An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells. Mutat Res 312:85-98.
24. Stankowski LF Jr, Tindall K, Hsie AW (1986): Quantitative and molecular analyses of ethyl methanesulfonate- and ICR 191-induced mutation in AS52 cells. Mutat Res 160:133-147.
25. Stopper H, Pechan R, Schiffmann D (1992): 5-Azacytidine induces micronuclei in and morphological transformation of Syrian hamster embryo fibroblasts in the absence of unscheduled DNA synthesis. Mutat Res 283:21-28.
26. Stopper H, Körber C, Schiffmann D, Caspary WJ (1993): Cell cycle dependent micronucleus formation and mitotic disturbances in mammalian cells treated with 5-azacytidine. Mutat Res 300:165-177.
27. Stopper H, Körber C, Gibis P, Spencer DL, Caspary WJ (1995): Micronuclei induced by modulators of methylation: Analogs of 5-azacytidine. Carcinogenesis 16:1647-1650.
28. Taylor SM, Jones PA (1982): Mechanism of action of eukaryotic DNA and methyltransferase. J Mol Biol 162:679-692.
29. Tindall KR, Stankowski LF Jr, Machanoff R, Hsie AW (1984): Detection of deletion mutations in pSV2gpt-transformed cells. Mol Cell Biol 4:1411-1415.
30. Von Hoff D, Slavik M, Muggia F (1976): 5-Azacytidine: A new anticancer drug with effectiveness in acute myelogenous leukemia. Ann Intern Med 85:237-245.
31. Walker C, Nettesheim P (1986): In vitro transformation of primary rat tracheal epithelial cells by 5-azacytidine. Cancer Res 46:6433-6437.
32. Walker C, Matthews A, Shay J (1987): Suppression of tumorigenicity mediated by 5-azacytidine and associated with increased chromosome number. J Natl Cancer Inst 78:695-700.
33. Zimmermann FK, Scheel I (1984): Genetic effects of 5-azacytidine in Saccharomyces cerevisiae. Mutat Res 139:21-24.